156 related articles for article (PubMed ID: 6423212)
1. Evidence for dopamine autoreceptors in mesocortical dopamine neurons.
Fadda F; Gessa GL; Marcou M; Mosca E; Rossetti Z
Brain Res; 1984 Feb; 293(1):67-72. PubMed ID: 6423212
[TBL] [Abstract][Full Text] [Related]
2. Regulation of dopamine synthesis in the medial prefrontal cortex is mediated by release modulating autoreceptors: studies in vivo.
Galloway MP; Wolf ME; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):689-98. PubMed ID: 3081705
[TBL] [Abstract][Full Text] [Related]
3. Absence of synthesis-modulating nerve terminal autoreceptors on mesoamygdaloid and other mesolimbic dopamine neuronal populations.
Kilts CD; Anderson CM; Ely TD; Nishita JK
J Neurosci; 1987 Dec; 7(12):3961-75. PubMed ID: 3121804
[TBL] [Abstract][Full Text] [Related]
4. Regulation of dopamine synthesis in the medial prefrontal cortex: studies in brain slices.
Wolf ME; Galloway MP; Roth RH
J Pharmacol Exp Ther; 1986 Mar; 236(3):699-707. PubMed ID: 2869140
[TBL] [Abstract][Full Text] [Related]
5. Delayed inhibition of dopamine synthesis by gamma-butyrolactone and baclofen: dopamine autoreceptor supersensitivity?
Argiolas A; Fadda F; Melis MR; Marcou M; Porceddu ML; Gessa GL
Eur J Pharmacol; 1982 Nov; 85(1):23-7. PubMed ID: 6818043
[TBL] [Abstract][Full Text] [Related]
6. Sustained high release at rapid stimulation rates and reduced functional autoreceptors characterize prefrontal cortex dopamine terminals.
Hoffmann IS; Talmaciu RK; Ferro CP; Cubeddu LX
J Pharmacol Exp Ther; 1988 Jun; 245(3):761-72. PubMed ID: 3385641
[TBL] [Abstract][Full Text] [Related]
7. Changes in sensitivity of release modulating dopamine autoreceptors after chronic treatment with haloperidol.
Nowak JZ; Arbilla S; Galzin AM; Langer SZ
J Pharmacol Exp Ther; 1983 Aug; 226(2):558-64. PubMed ID: 6875865
[TBL] [Abstract][Full Text] [Related]
8. Evidence for dopamine autoreceptors controlling dopamine synthesis in the substantia nigra.
Argiolas A; Melis MR; Fadda F; Gessa GL
Brain Res; 1982 Feb; 234(1):177-81. PubMed ID: 6800566
[TBL] [Abstract][Full Text] [Related]
9. Effect of dopamine agonists and antagonists on DOPA formation in the substantia nigra.
Argiolas A; Melis MR; Fadda F; Serra G; Gessa GL
J Neurochem; 1982 Jan; 38(1):75-9. PubMed ID: 6809898
[TBL] [Abstract][Full Text] [Related]
10. Evidence for the absence of impulse-regulating somatodendritic and synthesis-modulating nerve terminal autoreceptors on subpopulations of mesocortical dopamine neurons.
Chiodo LA; Bannon MJ; Grace AA; Roth RH; Bunney BS
Neuroscience; 1984 May; 12(1):1-16. PubMed ID: 6462443
[TBL] [Abstract][Full Text] [Related]
11. The effectiveness of yohimbine in blocking rat central dopamine autoreceptors in vivo.
van Oene JC; de Vries JB; Horn AS
Naunyn Schmiedebergs Arch Pharmacol; 1984 Oct; 327(4):304-11. PubMed ID: 6514014
[TBL] [Abstract][Full Text] [Related]
12. Supersensitivity of dopamine-autoreceptors. The effect of gammabutyrolactone in long-term haloperidol treated rats.
Stock G; Steinbrenner J; Kummer P
J Neural Transm; 1980; 47(2):145-51. PubMed ID: 7373289
[TBL] [Abstract][Full Text] [Related]
13. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
Devoto P; Flore G; Pani L; Gessa GL
Mol Psychiatry; 2001 Nov; 6(6):657-64. PubMed ID: 11673793
[TBL] [Abstract][Full Text] [Related]
14. Blockade of the noradrenaline carrier increases extracellular dopamine concentrations in the prefrontal cortex: evidence that dopamine is taken up in vivo by noradrenergic terminals.
Carboni E; Tanda GL; Frau R; Di Chiara G
J Neurochem; 1990 Sep; 55(3):1067-70. PubMed ID: 2117046
[TBL] [Abstract][Full Text] [Related]
15. Effects of isomers of hydroxyaporphines on dopamine metabolism in rat brain regions.
Baldessarini RJ; Marsh ER; Kula NS; Zong RS; Gao YG; Neumeyer JL
Biochem Pharmacol; 1990 Aug; 40(3):417-23. PubMed ID: 2383279
[TBL] [Abstract][Full Text] [Related]
16. Role of dopaminergic and serotonergic neuronal systems in the prefrontal cortex of rats in phencyclidine-induced behaviors.
Yamaguchi K; Nabeshima T; Kameyama T
J Pharmacobiodyn; 1986 Dec; 9(12):987-96. PubMed ID: 3572718
[TBL] [Abstract][Full Text] [Related]
17. Differential action of bromocriptine on nigrostriatal versus mesolimbic dopaminergic neurons.
Barton AC; Moore KE; Demarest KT
J Neural Transm; 1987; 68(1-2):25-39. PubMed ID: 2879883
[TBL] [Abstract][Full Text] [Related]
18. Dopamine autoreceptors modulate dopamine release from the prefrontal cortex.
Talmaciu RK; Hoffmann IS; Cubeddu LX
J Neurochem; 1986 Sep; 47(3):865-70. PubMed ID: 3734802
[TBL] [Abstract][Full Text] [Related]
19. Behavioural and biochemical effects of dopamine and noradrenaline depletion within the medial prefrontal cortex of the rat.
Carter CJ; Pycock CJ
Brain Res; 1980 Jun; 192(1):163-76. PubMed ID: 7189685
[TBL] [Abstract][Full Text] [Related]
20. Differential agonist profile of the enantiomers of 3-PPP at striatal dopamine autoreceptors: dependence on extracellular dopamine.
Clark D; Salah RS; Galloway MP
Synapse; 1991 Jul; 8(3):169-76. PubMed ID: 1948667
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
